Electronic Thesis/Dissertation


Therapeutic Ultrasound-Induced Insulin Release Open Access

Downloadable Content

Download PDF

Type 2 diabetes mellitus (T2DM) is a complex and chronic metabolic disease that results from the interplay of systemic insulin resistance of peripheral tissues and insufficient compensatory insulin secretion from pancreatic beta cells (American Diabetes Association, 2010; Kahn, 2001). The objective of this thesis was to investigate the safety and efficacy of low-frequency, low-intensity therapeutic ultrasound-induced insulin release as a non-pharmacological approach for modulating endogenous insulin concentrations in the early stages of T2DM. We utilized a preclinical in vivo murine model and multi-physics computational modeling of the human abdomen to assess the safety, feasibility, and efficacy of the proposed therapy. We observed an increase of 0.30 ± 0.32 ng/mL (mean ± std) in blood insulin concentration in vivo immediately after a five-minute sonication compared to a decrease of 0.37 ± 0.27 ng/mL in sham treated animals in terminal studies (n < 6, p < 0.005). There was no difference observed in the change in glucose or glucagon concentrations between the groups. Comparisons of H&E-stained; terminal and survival pancreatic tissue showed no visible differences or evidence of damage. Computational modeling studies showed that continuous sonication at 1 MHz through a fluid-filled stomach results in a maximum pressure of 181 kPa and maximum temperature of 39.7ºC. This study is the first step is assessing the translational potential of low-frequency, low-intensity therapeutic ultrasound as a potential treatment for the early stages of T2DM as we have demonstrated that it is feasible to safely and effectively modulate insulin release noninvasively.

Author Language Keyword Date created Type of Work Rights statement GW Unit Degree Advisor Committee Member(s) Persistent URL